• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过生物信息学和生物物理技术鉴定TRIM25在14-3-3σ上的肽结合序列。

Identification of peptide binding sequence of TRIM25 on 14-3-3σ by bioinformatics and biophysical techniques.

作者信息

Chiang De Chen, Teh Aik-Hong, Yap Beow Keat

机构信息

School of Pharmaceutical Sciences, Universiti Sains Malaysia, USM, Penang, Malaysia.

Centre for Chemical Biology, Universiti Sains Malaysia, Bayan Lepas, Penang, Malaysia.

出版信息

J Biomol Struct Dyn. 2023;41(22):13260-13270. doi: 10.1080/07391102.2023.2172458. Epub 2023 Feb 1.

DOI:10.1080/07391102.2023.2172458
PMID:36724456
Abstract

14-3-3σ protein is one of the seven isoforms from the highly conserved eukaryotic 14-3-3 protein family. Downregulation of 14-3-3σ expression has been observed in various tumors. TRIM25 is responsible for the proteolytic degradation of 14-3-3σ, in which abrogation of TRIM25 suppressed tumor growth through 14-3-3σ upregulation. However, to date, the exact 14-3-3σ interacting residues of TRIM25 have yet to be resolved. Thus, this study attempts to identify the peptide binding sequence of TRIM25 on 14-3-3σ via both bioinformatics and biophysical techniques. Multiple sequence alignment of the CC domain of TRIM25 revealed five potential peptide binding sequences (Peptide 1-5). Nuclear magnetic resonance (NMR) assay (H CPMG) identified Peptide 1 as an important sequence for binding to 14-3-3σ. Competition NMR assay suggested that Peptide 1 binds to the amphipathic pocket of 14-3-3σ with an estimated K of 116.4 µM by isothermal titration calorimetry. Further in silico docking and molecular dynamics simulations studies proposed that Peptide 1 is likely to interact with Lys49, Arg56, Arg129, and Tyr130 residues at the amphipathic pocket of 14-3-3σ. These results suggest that Peptide 1 may serve as a biological probe or a template to design inhibitors of TRIM25-14-3-3σ interaction as a potentially novel class of anticancer agents.Communicated by Ramaswamy H. Sarma.

摘要

14-3-3σ蛋白是高度保守的真核生物14-3-3蛋白家族的七种同工型之一。在各种肿瘤中均观察到14-3-3σ表达下调。TRIM25负责14-3-3σ的蛋白水解降解,其中TRIM25的缺失通过上调14-3-3σ抑制肿瘤生长。然而,迄今为止,TRIM25与14-3-3σ相互作用的确切残基尚未确定。因此,本研究试图通过生物信息学和生物物理技术鉴定TRIM25在14-3-3σ上的肽结合序列。TRIM25的CC结构域的多序列比对揭示了五个潜在的肽结合序列(肽1-5)。核磁共振(NMR)分析(H CPMG)确定肽1是与14-3-3σ结合的重要序列。竞争NMR分析表明,肽1通过等温滴定量热法以估计的K为116.4µM结合到14-3-3σ的两亲口袋。进一步的计算机对接和分子动力学模拟研究表明,肽1可能与14-3-3σ两亲口袋处的Lys49、Arg56、Arg129和Tyr130残基相互作用。这些结果表明,肽1可作为一种生物探针或模板来设计TRIM25-14-3-3σ相互作用的抑制剂,作为一类潜在的新型抗癌药物。由Ramaswamy H. Sarma传达。

相似文献

1
Identification of peptide binding sequence of TRIM25 on 14-3-3σ by bioinformatics and biophysical techniques.通过生物信息学和生物物理技术鉴定TRIM25在14-3-3σ上的肽结合序列。
J Biomol Struct Dyn. 2023;41(22):13260-13270. doi: 10.1080/07391102.2023.2172458. Epub 2023 Feb 1.
2
In Silico Prediction and Biophysical Validation of Novel 14-3-3σ Homodimer Stabilizers.新型 14-3-3σ 同二聚体稳定剂的计算预测与生物物理验证。
J Chem Inf Model. 2023 Sep 11;63(17):5619-5630. doi: 10.1021/acs.jcim.3c00791. Epub 2023 Aug 22.
3
Insight into conformational change for 14-3-3σ protein by molecular dynamics simulation.通过分子动力学模拟洞察14-3-3σ蛋白的构象变化。
Int J Mol Sci. 2014 Feb 18;15(2):2794-810. doi: 10.3390/ijms15022794.
4
Identification of 14-3-3 Proteins Phosphopeptide-Binding Specificity Using an Affinity-Based Computational Approach.使用基于亲和力的计算方法鉴定14-3-3蛋白磷酸肽结合特异性
PLoS One. 2016 Feb 1;11(2):e0147467. doi: 10.1371/journal.pone.0147467. eCollection 2016.
5
Adoption of a Turn Conformation Drives the Binding Affinity of p53 C-Terminal Domain Peptides to 14-3-3σ.构象转换的采用驱动 p53 C 端结构域肽与 14-3-3σ 的结合亲和力。
ACS Chem Biol. 2020 Jan 17;15(1):262-271. doi: 10.1021/acschembio.9b00893. Epub 2020 Jan 3.
6
Recognition of lysine-rich peptide ligands by murine cortactin SH3 domain: CD, ITC, and NMR studies.鼠源 cortactin SH3 结构域识别富含赖氨酸的肽配体:CD、ITC 和 NMR 研究。
Biopolymers. 2010;94(3):298-306. doi: 10.1002/bip.21350.
7
TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ.TRIM25通过下调14-3-3σ与非小细胞肺癌A549细胞系中的顺铂耐药相关。
Biochem Biophys Res Commun. 2017 Nov 4;493(1):568-572. doi: 10.1016/j.bbrc.2017.08.151. Epub 2017 Sep 1.
8
The crystal structure of the non-liganded 14-3-3sigma protein: insights into determinants of isoform specific ligand binding and dimerization.非配体结合型14-3-3σ蛋白的晶体结构:对异构体特异性配体结合和二聚化决定因素的见解。
Cell Res. 2005 Apr;15(4):219-27. doi: 10.1038/sj.cr.7290290.
9
A Phosphorylation-Induced Switch in the Nuclear Localization Sequence of the Intrinsically Disordered NUPR1 Hampers Binding to Importin.磷酸化诱导无规则卷曲 NUPR1 核定位序列开关阻碍与 Importin 的结合。
Biomolecules. 2020 Sep 11;10(9):1313. doi: 10.3390/biom10091313.
10
Amphipathic helical peptides hamper protein-protein interactions of the intrinsically disordered chromatin nuclear protein 1 (NUPR1).两亲性螺旋肽可干扰固有无序染色质核蛋白 1(NUPR1)的蛋白质-蛋白质相互作用。
Biochim Biophys Acta Gen Subj. 2018 Jun;1862(6):1283-1295. doi: 10.1016/j.bbagen.2018.03.009. Epub 2018 Mar 10.

引用本文的文献

1
TRIM25: A Global Player of Cell Death Pathways and Promising Target of Tumor-Sensitizing Therapies.TRIM25:细胞死亡途径的全球参与者及肿瘤增敏治疗的潜在靶点
Cells. 2025 Jan 7;14(2):65. doi: 10.3390/cells14020065.
2
TRIM25, TRIM28 and TRIM59 and Their Protein Partners in Cancer Signaling Crosstalk: Potential Novel Therapeutic Targets for Cancer.TRIM25、TRIM28和TRIM59及其在癌症信号串扰中的蛋白质伙伴:癌症潜在的新型治疗靶点
Curr Issues Mol Biol. 2024 Sep 25;46(10):10745-10761. doi: 10.3390/cimb46100638.